000 01273 a2200337 4500
005 20250516140631.0
264 0 _c20130730
008 201307s 0 0 eng d
022 _a1862-3514
024 7 _a10.1007/s11657-013-0128-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBurden, Andrea M
245 0 0 _aVariation in the days supply field for osteoporosis medications in Ontario.
_h[electronic resource]
260 _bArchives of osteoporosis
_c2013
300 _a128 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aBone Density Conservation Agents
_xadministration & dosage
650 0 4 _aDiphosphonates
_xadministration & dosage
650 0 4 _aDrug Prescriptions
_xstatistics & numerical data
650 0 4 _aDrug Utilization
_xstatistics & numerical data
650 0 4 _aHumans
650 0 4 _aImidazoles
_xadministration & dosage
650 0 4 _aOntario
_xepidemiology
650 0 4 _aOsteoporosis
_xdrug therapy
650 0 4 _aZoledronic Acid
700 1 _aHuang, Anjie
700 1 _aTadrous, Mina
700 1 _aCadarette, Suzanne M
773 0 _tArchives of osteoporosis
_gvol. 8
_gp. 128
856 4 0 _uhttps://doi.org/10.1007/s11657-013-0128-1
_zAvailable from publisher's website
999 _c22567698
_d22567698